Found 51 matching trials
Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects PHASE4 The purpose of this study is explore the antibody and cell mediated immune ...
Show More Location
Azienda Ospedaliera Universtaria Senese
Learn More & Join Trial
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age PHASE3 This study will evaluate the safety and immunogenicity in healthy children ...
Show More Location
Centro de Atención e Investigación Medica - CAIMED
Learn More & Join Trial
Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine N/A This is an observational safety study of a prophylactic use of Flu Egg Deri...
Show More Location
Hospital Garrahan
Learn More & Join Trial
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects PHASE3 The present study will evaluate clinical efficacy, safety, tolerability and...
Show More Learn More & Join Trial
Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine PHASE3 The purpose of this study is to compare immunogenicity and safety of ASP737...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age PHASE3 A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Show More Location
MHAT St. Ekaterina
Learn More & Join Trial
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects PHASE3 The purpose of this study is to describe the immunogenicity and safety of t...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age PHASE3 Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...
Show More Location
320, Novartis Investigational Site
Learn More & Join Trial
Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age PHASE2 The present study is designed to confirm the safety and immunogenicity of t...
Show More Location
Antwerp University Centre for the Evaluation of Vaccination
Learn More & Join Trial
Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults PHASE2 The purpose of this study is to evaluate the safety and immunogenicity of c...
Show More Location
Multiple Locations
Learn More & Join Trial